| 5-hydroxyeicosatetraenoic-acid inhibitor | 35222 | An agent that blocks the activity of 5-lipoxygenase, reducing leukotriene production and inflammation. Therapeutically, it's used to treat asthma, allergic rhinitis, and other inflammatory conditions, providing relief from symptoms such as congestion and bronchospasm. | DUKE |
| 5-hydroxytryptamine inhibitor | 48279 | An agent that blocks the activity of 5-hydroxytryptamine (serotonin), reducing its effects on various bodily functions. Therapeutically, it is used to treat conditions like carcinoid syndrome, migraine, and irritable bowel syndrome, managing symptoms such as diarrhea, flushing, and abdominal pain. | DUKE |
| 5-lipoxygenase inhibitor | 23924 | An agent that blocks the activity of 5-lipoxygenase, an enzyme involved in leukotriene production, reducing inflammation and allergic responses. Therapeutically, it's used to treat asthma, allergies, and inflammatory disorders, such as arthritis, by inhibiting the synthesis of pro-inflammatory leukotrienes. | DUKE |
| Serine/threonine kinase inhibitor | 50925 | An agent that blocks the activity of serine/threonine kinases, enzymes involved in cell signaling and division. It has therapeutic applications in cancer, neurodegenerative, and inflammatory diseases, with key medical uses including cancer treatment and managing neurological disorders. | DUKE |
| Anti-aggregant | | An agent that prevents platelet aggregation, reducing blood clot formation. Its biological role is to inhibit platelet activation, and its therapeutic applications include preventing thrombosis and stroke. Key medical uses include treating cardiovascular diseases, such as myocardial infarction and atrial fibrillation, and managing conditions that increase the risk of blood clots. | DUKE |
| Anti-angiogenic | 48422 | An agent that inhibits the formation of new blood vessels, playing a crucial role in cancer treatment by starving tumors of oxygen and nutrients. Therapeutically, it is used to manage cancer, age-related macular degeneration, and other diseases characterized by excessive angiogenesis, reducing tumor growth and slowing disease progression. | DUKE |
| Anti bacterial | 33282 | An agent that inhibits the growth of or destroys bacteria, playing a crucial role in preventing and treating infections. Therapeutically, it is used to combat bacterial infections, with key medical applications including treating pneumonia, tuberculosis, and skin infections, as well as preventing surgical site infections and sepsis. | DUKE |
| Anti-cancer | 35610 | An agent that inhibits the growth and proliferation of cancer cells, used to treat and manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, to reduce tumor size, prevent metastasis, and improve patient survival. | DUKE |
| Anti carcinogenic | 35610 | An agent that prevents or inhibits the formation of cancer, reducing tumor growth and proliferation. It plays a biological role in protecting cells from DNA damage and mutation. Therapeutically, it is used to prevent cancer development, with key medical applications in chemotherapy, radiation protection, and cancer prevention programs. | DUKE |
| Anti-edemic | | An agent that relieves or prevents edema, reducing abnormal fluid accumulation in tissues or the circulatory system, commonly used to treat conditions such as swelling, inflammation, and water retention. | DUKE |
| Anti eicosanoid | 35222 | An agent that inhibits the production or activity of eicosanoids, reducing inflammation and allergic responses. Therapeutically, it's used to manage conditions like asthma, arthritis, and allergic disorders, providing relief from symptoms such as pain and inflammation. | DUKE |
| Anti-inflammatory | 35472 | An agent that reduces inflammation, playing a biological role in suppressing immune responses and therapeutic applications in managing pain, swelling, and redness. Key medical uses include treating arthritis, allergies, and autoimmune disorders, as well as relieving symptoms of conditions such as asthma and dermatitis. | DUKE |
| Anti leukemic | 35610 | An agent that targets and inhibits the growth of leukemia cells, playing a crucial role in cancer treatment. Therapeutically, it is used to induce remission, manage symptoms, and improve survival rates in patients with leukemia. Key medical uses include treating acute and chronic leukemia, lymphoma, and other hematological malignancies. | DUKE |
| Anti leukotriene | 35222 | An agent that blocks the action of leukotrienes, reducing inflammation and bronchoconstriction. Therapeutically, it is used to treat asthma, allergic rhinitis, and other respiratory disorders by inhibiting the biological role of leukotrienes in mediating inflammatory responses. | DUKE |
| Anti lipoperoxidant | | An agent that prevents peroxidation of lipids, reducing oxidative stress and cell damage. Its biological role involves protecting cell membranes from degradation. Therapeutically, it has applications in managing conditions related to oxidative stress, with key medical uses including neuroprotection, anti-inflammation, and antioxidant therapy. | DUKE |
| Anti-mutagenic | | An agent that interferes with the mutagenicity of a substance, preventing DNA damage and mutations. Its biological role is to protect cells from genetic alterations, and it has therapeutic applications in cancer prevention and treatment, as well as key medical uses in reducing the risk of genetic disorders and birth defects. | DUKE |
| Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE |
| Anti peroxidant | | An agent that prevents oxygen atom and peroxide formation, reducing oxidative stress and cell damage. It plays a biological role in protecting cells from free radicals. Therapeutically, it's used to manage conditions like cancer, Alzheimer's, and atherosclerosis, with key medical applications in neuroprotection, cardiovascular health, and anti-aging. | DUKE |
| Anti proliferant | | An agent that prevents or inhibits cell growth and division, used therapeutically to treat cancer, manage tumor growth, and prevent restenosis after angioplasty, reducing abnormal cell proliferation. | DUKE |
| Anti prostaglandin | 49020 | An agent that inhibits prostaglandin production, reducing inflammation and pain. Therapeutically, it's used to treat conditions like arthritis, menstrual cramps, and post-surgical pain, by blocking prostaglandin-mediated responses, providing relief from inflammation and discomfort. | DUKE |
| Anti radicular | | An agent that relieves inflammation or irritation of the nerve root of a tooth, reducing pain and discomfort. Its biological role is to target and alleviate radicular pain, with therapeutic applications in endodontics and key medical uses in root canal treatments and tooth sensitivity management. | DUKE |
| Anti septic | 33281 | An agent that prevents or reduces the growth of microorganisms, such as bacteria, fungi, or viruses, to promote wound healing and prevent infection. Therapeutically, anti septics are used to treat minor cuts, scrapes, and burns, and are commonly applied topically to reduce the risk of infection and promote tissue repair. Key medical uses include wound care, surgical site preparation, and skin infection management. | DUKE |
| Anti-thrombic | 50248 | An agent that prevents or dissolves blood clots, playing a crucial role in preventing thrombosis. Therapeutically, it is used to reduce the risk of heart attack, stroke, and deep vein thrombosis, commonly used in managing cardiovascular diseases, atrial fibrillation, and post-surgical patients. | DUKE |
| Antitumor | 35610 | An agent that inhibits tumor growth and proliferation, playing a crucial role in cancer treatment. Therapeutically, antitumors are used to manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, helping to reduce tumor size, prevent metastasis, and improve patient outcomes. | DUKE |
| Apoptotic | | An agent that stimulates programmed cell death, playing a crucial biological role in eliminating damaged or unwanted cells. It has therapeutic applications in cancer treatment, and key medical uses include inducing cell death in malignant cells, reducing tumor growth, and enhancing chemotherapy efficacy. | DUKE |
| Artemicide | | An herbicidal agent that targets and eliminates weeds of the Artemisia genus, with potential therapeutic applications in allergy management and anti-inflammatory uses, particularly for conditions exacerbated by Artemisia allergens. | DUKE |
| Beta-glucuronidase inhibitor | 23924 | An agent that blocks the activity of beta-glucuronidase, an enzyme that breaks down glucuronides. It reduces the toxicity of certain drugs and is used to manage conditions like cancer, inflammatory bowel disease, and irinotecan-induced diarrhea, improving treatment outcomes and reducing side effects. | DUKE |
| Cardioprotective | 38070 | An agent that protects the heart from damage, reducing the risk of cardiovascular disease. It plays a biological role in mitigating cardiac stress and injury, with therapeutic applications in preventing heart attacks, strokes, and arrhythmias, and key medical uses in treating hypertension, heart failure, and coronary artery disease. | DUKE |
| Casein-kinase-II inhibitor | 23924 | An agent that blocks casein kinase II activity, regulating cell signaling and proliferation. It has therapeutic applications in cancer, neurodegenerative diseases, and viral infections, with key medical uses including anticancer and antiviral treatments. | DUKE |
| Chemopreventive | 35610 | An agent that prevents or delays the development of cancer, reducing the risk of tumor formation and progression. It plays a biological role in inhibiting carcinogenesis, and has therapeutic applications in cancer prevention, with key medical uses including reducing the risk of colorectal, breast, and prostate cancers. | DUKE |
| Cyclooxygenase-1 inhibitor | 50630 | An agent that blocks the activity of cyclooxygenase-1 (COX-1), reducing inflammation and pain. Therapeutically, it is used to manage conditions like arthritis, and as a nonsteroidal anti-inflammatory drug (NSAID) to relieve pain, fever, and inflammation, while minimizing gastrointestinal side effects. | DUKE |
| Cyclooxygenase-2 inhibitor | 50629 | An agent that blocks the activity of cyclooxygenase-2 (COX-2), reducing inflammation and pain. Therapeutically, it is used to manage conditions such as arthritis, menstrual cramps, and other inflammatory disorders, providing relief from symptoms with reduced gastrointestinal side effects compared to non-selective NSAIDs. | DUKE |
| Cyclooxygenase inhibitor | 35544 | An agent that blocks the activity of cyclooxygenase enzymes, reducing inflammation and pain. Therapeutically, it is used to treat conditions such as arthritis, headaches, and menstrual cramps, by decreasing prostaglandin production, a key mediator of inflammation. | DUKE |
| Cytochrome-CYP1A1 inhibitor | 35222 | An agent that blocks the activity of cytochrome CYP1A1, an enzyme involved in metabolizing toxins and carcinogens. It reduces the risk of cancer and toxicity, with potential therapeutic applications in cancer prevention and treatment, as well as managing conditions related to environmental toxin exposure. | DUKE |
| Differentiator | | An agent that induces cell differentiation, promoting mature cell formation. Its biological role involves regulating cell growth and development. Therapeutically, it has applications in cancer treatment, helping to mature cancer cells, making them more susceptible to chemotherapy. Key medical uses include leukemia and other malignancies, where differentiation therapy can improve treatment outcomes. | DUKE |
| Elastase inhibitor | 23924 | An agent that blocks the activity of elastase, an enzyme that breaks down elastin, reducing tissue damage and inflammation. Therapeutically, it's used to manage conditions like chronic obstructive pulmonary disease (COPD), cystic fibrosis, and emphysema, protecting lung tissue and improving respiratory function. | DUKE |
| Estrogenic | | An agent that mimics the effects of estrogen, regulating female reproductive processes and development. Therapeutically, estrogenic agents are used in hormone replacement therapy, contraception, and treating menopausal symptoms, as well as certain cases of osteoporosis and infertility. | DUKE |
| Fungicide | 24127 | An agent that kills or inhibits the growth of fungi, playing a biological role in preventing fungal infections. Therapeutically, it is used to treat fungal diseases, with key medical applications including athlete's foot, ringworm, and candidiasis, as well as agricultural uses to protect crops from fungal damage. | DUKE |
| Hepatoprotective | 62868 | An agent that protects the liver from damage, promoting liver health and function. It plays a biological role in reducing oxidative stress and inflammation, and has therapeutic applications in managing liver diseases, such as hepatitis and cirrhosis, and key medical uses in treating drug-induced liver injury and toxicities. | DUKE |
| HIF-1alpha inhibitor | 35222 | An agent that blocks the activity of hypoxia-inducible factor-1 alpha, reducing angiogenesis and tumor growth. Therapeutically, it has applications in cancer treatment, particularly for solid tumors, and may also be used to manage conditions involving excessive angiogenesis, such as retinal diseases. | DUKE |
| Hydroperoxidase inhibitor | 23924 | An agent that blocks the activity of hydroperoxidase enzymes, reducing oxidative stress and inflammation. Therapeutically, it's used to manage conditions like cancer, neurodegenerative diseases, and cardiovascular disorders by mitigating cell damage caused by reactive oxygen species. | DUKE |
| Hypocholesterolemic | | An agent that lowers cholesterol levels in the blood, playing a crucial role in preventing cardiovascular disease. Therapeutically, it is used to manage hyperlipidemia and reduce the risk of heart disease, with key medical applications including the treatment of high cholesterol, atherosclerosis, and coronary artery disease. | DUKE |
| Hypotriglyceridemic | | An agent that lowers triglyceride levels in the blood, playing a role in lipid metabolism. Therapeutically, it helps manage hypertriglyceridemia, reducing the risk of cardiovascular disease and pancreatitis, with key medical uses in treating dyslipidemia and preventing atherosclerosis. | DUKE |
| IKB-kinase inhibitor | 23924 | An agent that blocks the activity of IKB-kinase, reducing inflammation and immune responses. Therapeutically, it's used to treat autoimmune diseases, cancers, and inflammatory disorders, such as rheumatoid arthritis and asthma, by inhibiting NF-_B signaling pathways. | DUKE |
| JNK inhibitor | 23924 | An agent that blocks the activity of c-Jun N-terminal kinase (JNK), reducing inflammation and apoptosis. Therapeutically, it has applications in treating neurodegenerative diseases, cancer, and autoimmune disorders, with key medical uses including managing Alzheimer's, Parkinson's, and rheumatoid arthritis. | DUKE |
| Lipolytic | | An agent that stimulates hydrolysis of fats into fatty acids and glycerol, playing a key biological role in fat metabolism. Therapeutically, lipolytics have applications in managing obesity and hypertriglyceridemia, with medical uses including weight loss and improving lipid profiles. | DUKE |
| Mitogen-activated-protein-kinase inhibitor | 23924 | An agent that blocks the activity of mitogen-activated protein kinases, reducing inflammation and cell proliferation. Therapeutically, it's used to treat cancer, autoimmune diseases, and neurodegenerative disorders, by inhibiting signaling pathways involved in disease progression. | DUKE |
| NADH-ubiquinone-oxidoreductase inhibitor | 50390 | An agent that blocks the activity of NADH-ubiquinone-oxidoreductase, a key enzyme in mitochondrial electron transport. It has therapeutic applications in managing neurodegenerative diseases, cancer, and infectious diseases, with key medical uses including anti-cancer and anti-parasitic treatments. | DUKE |
| NF-kappa-B inhibitor | 35222 | An agent that blocks the activity of NF-kappa-B, a protein complex involved in inflammation and immune responses, reducing inflammation and cell proliferation. Therapeutically, it is used to treat conditions such as cancer, autoimmune disorders, and inflammatory diseases, including rheumatoid arthritis and asthma. | DUKE |
| Ornithine-decarboxylase inhibitor | 23924 | An agent that blocks the activity of ornithine decarboxylase, an enzyme involved in cell growth and proliferation. It reduces polyamine synthesis, inhibiting tumor growth and proliferation. Therapeutically, it is used to treat cancer, particularly in combination with other therapies, and has potential applications in managing parasitic infections and skin disorders. | DUKE |
| Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE |
| Phytoalexin | 26115 | A plant-derived compound that plays a biological role in defense against pathogens. It has therapeutic applications as an antimicrobial, antioxidant, and anti-inflammatory agent, with key medical uses in managing infections, cancer, and neurodegenerative diseases. | DUKE |
| Protein kinase C inhibitor | 37700 | An agent that blocks protein kinase C activity, reducing cell signaling and inflammation. Therapeutically, it's used to treat cancer, cardiovascular diseases, and neurological disorders, with key medical applications in managing Alzheimer's disease, diabetes, and stroke. | DUKE |
| Protein kinase D inhibitor | 37699 | An agent that blocks the activity of protein kinase D, reducing cell signaling and proliferation. It has therapeutic applications in cancer, cardiovascular disease, and inflammatory disorders, with key medical uses including cancer treatment and prevention of tumor growth and metastasis. | DUKE |
| Protein-tyrosine-kinase inhibitor | 23924 | An agent that blocks the activity of protein-tyrosine kinases, enzymes involved in cell signaling and growth. Therapeutically, it reduces abnormal cell proliferation, commonly used in managing cancer, particularly leukemia and solid tumors, by inhibiting tumor growth and angiogenesis. | DUKE |
| Quinone-reductase inducer | | An agent that stimulates quinone reductase enzymatic activity, enhancing cellular antioxidant defenses and protecting against carcinogens, with therapeutic applications in cancer chemoprevention and potential uses in managing oxidative stress-related diseases. | DUKE |
| Topoisomerase-II inhibitor | 50750 | An agent that blocks the activity of topoisomerase-II, an enzyme involved in DNA replication. It prevents cancer cell growth by disrupting DNA structure, commonly used in chemotherapy to treat various types of cancer, including leukemia and lymphoma. | DUKE |
| VEGF inhibitor | 35222 | An agent that blocks the activity of Vascular Endothelial Growth Factor (VEGF), reducing angiogenesis. Therapeutically, it's used to treat cancer, age-related macular degeneration, and diabetic retinopathy by inhibiting tumor growth and abnormal blood vessel formation. | DUKE |
